Clinical Trial Update: Effectiveness of Bazedoxifene for Prevention of Glucocorticoid-induced Bone Loss in RA Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the effectiveness of bazedoxifene in preventing glucocorticoid-induced bone loss in rheumatoid arthritis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucocorticoid-induced Osteoporosis
• Rheumatoid Arthritis

Drugs mentioned

• Bazedoxifene (bazedoxifene)

Snippet

Sponsor: Hanyang University | Conditions: Arthritis, Rheumatoid | Phase 4 | Status: COMPLETED